SARS-CoV-2 Vaccination Complicated by Small Fiber Neuropathy, Mast Cell Activation Syndrome, and Pericarditis

January 2023 in “ Clinics ”

Danice Hertz, Fúlvio A. Scorza, Ana C. Fiorini, Josef Finsterer

small fiber neuropathy mast cell activation syndrome pericarditis mRNA-based SARS-CoV-2 vaccination dysautonomia gastrointestinal issues excessive hair loss

Studysummary This commentary reports the first case of small fiber neuropathy, mast cell activation syndrome, and pericarditis following mRNA-based SARS-CoV-2 vaccination in a previously healthy 66-year-old woman.

Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer ·

View this study on linkinghub.elsevier.com →

Discuss this study in the Community →

Similar Research

5 / 1000+ results

research Viruses, Variants, and Vaccines: How COVID-19 Has Changed the Way We Look at Skin

1 citations , October 2022 in “Current Dermatology Reports”

This review discusses various skin reactions after SARS-CoV-2 infection and COVID-19 vaccination, noting a higher incidence with mRNA vaccines than adenovirus vector vaccines, and reports no new clinical results.

research Exacerbation of systemic lupus erythematosus after receiving mRNA‐1273‐based coronavirus disease 2019 vaccine

7 citations , February 2022 in “The Journal of Dermatology”

This case report suggests that the mRNA-1273 COVID-19 vaccine may induce systemic lupus erythematosus exacerbation, as observed in a 41-year-old woman who experienced worsened skin symptoms and other complications after vaccination.

Asymptomatic SARS-CoV-2 Infection or COVID-19 Vaccination Effect for Severe Multisystem Inflammatory Syndrome in a 6-Year-Old Girl: Case Report and Review of the Literature

research Asymptomatic SARS-COV2 Infection or COVID-19 vaccination effect for severe multisystem inflammatory syndrome in a 6-year-old girl: case report and review of the literature

September 2024 in “The Italian Journal of Pediatrics/Italian journal of pediatrics”

This case report describes a 6-year-old girl who developed MIS-C following COVID-19 vaccination, raising questions about the vaccine's potential role in its pathogenesis for children aged 5 to 11.

research Multisystem Inflammatory Syndrome in Adults (MIS-A) and SARS-CoV2: An Evolving Relationship

15 citations , March 2023 in “BioMed”

This review discusses multisystem inflammatory syndrome in adults (MIS-A) related to SARS-CoV2 and outlines the existing knowledge and unanswered questions, reporting no new clinical results.

research A case of severe autoimmune hemolytic anemia after a receipt of a first dose of SARS‐CoV‐2 vaccine

23 citations , July 2021 in “International journal of laboratory hematology”

This report describes an 84-year-old man who developed severe autoimmune hemolytic anemia after receiving the first dose of the Pfizer-BioNTech COVID-19 vaccine, highlighting a potential, rare side effect without proving causation.